Trends in hospitalization and death rates among patients with head and neck cancer in Spain, 2009 to 2019

References

• Chow LQM. Head and neck cancer. N Engl J Med. 2020;382(1):1–14. doi:10.1056/NEJMra1715715.
   PubMed Web of Science ®Google Scholar
• Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Prim. 2020;6(1):92. doi:10.1038/s41572-020-00224-3.
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Hashibe M, Brennan P, Chuang SC, Boccia S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev. 2009;18(2):541–550. doi:10.1158/1055-9965.epi-08-0347.
   PubMed Web of Science ®Google Scholar
• Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni JF Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282–3287.
   PubMed Web of Science ®Google Scholar
• Elrefaey S, Massaro MA, Chiocca S, Chiesa F, Ansarin M. HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital. 2014;34:299–309.
   PubMed Web of Science ®Google Scholar
• Gotz C, Bischof C, Wolff KD, Kolk A. Detection of HPV infection in head and neck cancers: promise and pitfalls in the last ten years: a meta-analysis. Mol Clin Oncol. 2019;10(1):17–28. doi:10.3892/mco.2018.1749.
   PubMed Web of Science ®Google Scholar
• Wagner S, Sharma SJ, Wuerdemann N, Knuth J, Reder H, Wittekindt C, Klussmann JP. Human papillomavirus-related head and neck cancer. Oncol Res Treat. 2017;40(6):334–340. doi:10.1159/000477252.
   PubMed Web of Science ®Google Scholar
• Faraji F, Eisele DW, Fakhry C. Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma. Laryngoscope Investig Otolaryngol. 2017;2(1):10–18. doi:10.1002/lio2.37.
   PubMed Web of Science ®Google Scholar
• Li H, Torabi SJ, Yarbrough WG, Mehra S, Osborn HA, Judson B. Association of human papillomavirus status at head and neck carcinoma subsites with overall survival. JAMA Otolaryngol Head Neck Surg. 2018;144(6):519–525. doi:10.1001/jamaoto.2018.0395.
   PubMed Web of Science ®Google Scholar
• Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wang MB. The “new” head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation. Otolaryngol Head Neck Surg (1979). 2014;151(3):375–380. doi:10.1177/0194599814538605.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO global report on trends in prevalence of tobacco smoking 2000–2025, Second edition. [accessed 2021 Dec 21]. https://www.who.int/tobacco/publications/surveillance/trends-tobacco-smoking-second-edition/en/
   Google Scholar
• Centre for Addiction and Mental Health. Public health gains and missed opportunities. Trends in alcohol consumption and attributable mortality in the WHO European Region, 1990-2014; 2016.
   Google Scholar
• Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–4301. doi:10.1200/jco.2011.36.4596.
   PubMed Web of Science ®Google Scholar
• Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts S. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer–systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35(5):747–755. doi:10.1002/hed.22015.
   PubMed Web of Science ®Google Scholar
• Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, Rosenberg PS, Bray F, Gillison ML. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013;31(36):4550–4559. doi:10.1200/jco.2013.50.3870.
   PubMed Web of Science ®Google Scholar
• Mahal BA, Catalano PJ, Haddad RI, Hanna GJ, Kass JI, Schoenfeld JD, Tishler RB, Margalit DN. Incidence and demographic burden of HPV-associated oropharyngeal head and neck cancers in the United States. Cancer Epidemiol Biomarkers Prev. 2019;28(10):1660–1667. doi:10.1158/1055-9965.epi-19-0038.
   PubMed Web of Science ®Google Scholar
• Smith EM, Ritchie JM, Summersgill KF, Klussmann JP, Lee JH, Wang D, Haugen TH, Turek LP. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer. 2004;108(5):766–772. doi:10.1002/ijc.11633.
   PubMed Web of Science ®Google Scholar
• D’-Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199(9):1263–1269. doi:10.1086/597755.
   PubMed Web of Science ®Google Scholar
• Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010;15(9):994–1001. doi:10.1634/theoncologist.2009-0289.
   PubMed Web of Science ®Google Scholar
• Gogarty DS, Shuman A, O’-Sullivan EM, Sheahan P, Kinsella J, Timon C, O’-Neill JP. Conceiving a national head and neck cancer screening programme. J Laryngol Otol. 2015;130(1):8–14. doi:10.1017/S0022215115003084.
   PubMed Web of Science ®Google Scholar
• Shuman AG, Entezami P, Chernin AS, Wallace NE, Taylor JM, Hogikyan ND. Demographics and efficacy of head and neck cancer screening. Otolaryngol Head Neck Surg (1979). 2010;143(3):353–360. doi:10.1016/j.otohns.2010.05.029.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Hisamatsu K, Suzui N, Hara A, Tomita H, Miyazaki T. A review of HPV-related head and neck cancer. J Clin Med. 2018;7(9):241. doi:10.3390/jcm7090241.
   PubMed Web of Science ®Google Scholar
• Guo T, Eisele DW, Fakhry C. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Cancer. 2016;122(15):2313–2323. doi:10.1002/cncr.29992.
   PubMed Web of Science ®Google Scholar
• Lee JM, Turini M, Botteman MF, Stephens JM, Pashos CL. Economic burden of head and neck cancer. A literature review. Eur J Health Econ. 2004;5(1):70–80. doi:10.1007/s10198-003-0204-3.
   PubMedGoogle Scholar
• Wissinger E, Griebsch I, Lungershausen J, Foster T, Pashos CL. The economic burden of head and neck cancer: a systematic literature review. Pharmacoeconomics. 2014;32(9):865–882. doi:10.1007/s40273-014-0169-3.
   PubMed Web of Science ®Google Scholar
• Ministerio de Sanidad y Consumo. Agencia de Calidad del Sistema Nacional de Salud. Instituto de Información Sanitaria. Metodología de análisis de la hospitalización en el sistema nacional de salud. Modelo de indicadores basado en el registro de altas (CMBD). [accessed 2021 Nov 26]. https://www.mscbs.gob.es/estadEstudios/estadisticas/docs/metod_modelo_cmbd_pub.pdf
   Google Scholar
• Rodríguez Del Águila M, Perea-Milla E, Librero J, BuzónBarrera M, Rivas Ruiz F Atlas VPM Nº 4. Análisis del control de calidad del Conjunto Mínimo de Datos Básicos de Andalucía en los años 2000 a 2003. Sevilla. [accessed 2021 Nov 26]. https://www.atlasvpm.org/atlas/atlas-no4-variaciones-en-la-hospitalizacion-por-problemas-y-procedimientos-cardiovasculares-en-el-sistema-nacional-de-salud/
   Google Scholar
• Instituto Nacional de Estadística (INE). Demography and population. [accessed 2021 Nov 26]. https://ine.es/dyngs/INEbase/en/categoria.htm?c=Estadistica_P&cid=1254734710984
   Google Scholar
• de Souza DL, Bxernal-Pérez MMB, Curado MP. Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control. Cancer Epidemiol. 2011;35(6):510–514. doi:10.1016/j.canep.2011.02.012.
   PubMed Web of Science ®Google Scholar
• Gil-Prieto R, Viguera-Ester P, Álvaro-Meca A, San-Martín-Rodriguez M, Gil de Miguel Á. The burden of hospitalizations for head and neck neoplasm in Spain (1997-2008): an epidemiologic study. Hum Vaccin Immunother. 2012;8(6):788–798. doi:10.4161/hv.19819.
   PubMed Web of Science ®Google Scholar
• Monteiro LS, Antunes L, Bento MJ, Warnakulasuriya S. Incidence rates and trends of lip, oral and oro-pharyngeal cancers in Portugal. J Oral Pathol Med. 2013;42(4):345–351. doi:10.1111/jop.12010.
   PubMed Web of Science ®Google Scholar
• Schernberg A, Sagaon-Teyssier L, Schwarzinger M. Clinical and economic burden of head and neck cancer: a nationwide retrospective cohort study from France. Clinicoecon Outcomes Res. 2019;11:441–451. doi:10.2147/ceor.s198312.
   PubMed Web of Science ®Google Scholar
• Boscolo-Rizzo P, Zorzi M, Del Mistro A, Da Mosto MC, Tirelli G, Buzzoni C, Rugge M, Polesel J, Guzzinati S, Group AW. The evolution of the epidemiological landscape of head and neck cancer in Italy: is there evidence for an increase in the incidence of potentially HPV-related carcinomas? PLoS One. 2018;13(2):e0192621. doi:10.1371/journal.pone.0192621.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. doi:10.3322/caac.21654.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Shao X, Wang X, Liu L, Liang H. Sex disparities in cancer. Cancer Lett. 2019;466:35–38. doi:10.1016/j.canlet.2019.08.017.
   PubMed Web of Science ®Google Scholar
• Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, Devesa SS, McGlynn KA. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1174–1182. doi:10.1158/1055-9965.EPI-08-1118.
   PubMed Web of Science ®Google Scholar
• Lubin JH, Gaudet MM, Olshan AF, Kelsey K, Boffetta P, Brennan P, Castellsague X, Chen C, Curado MP, Dal Maso L, et al. Body mass index, cigarette smoking, and alcohol consumption and cancers of the oral cavity, pharynx, and larynx: modeling odds ratios in pooled case-control data. Am J Epidemiol. 2010;171(12):1250–1261. doi:10.1093/aje/kwq088.
   PubMed Web of Science ®Google Scholar
• Ministerio de Sanidad CyBS. Informe Anual del Sistema Nacional de Salud 2019. [accessed 2021 Dec 20]. https://www.mscbs.gob.es/estadEstudios/estadisticas/sisInfSanSNS/tablasEstadisticas/InfAnualSNS2019/Informe_SNS_2019.pdf
   Google Scholar
• García-Mayor J, Moreno-Llamas A, De la Cruz-Sánchez E. Prevalencia de tabaquismo y hábitos de vida relacionados con la salud en función del uso del tabaco tras la implantación de la Ley 42/2010: análisis de encuestas de salud en España 2009-2017. Rev Esp Salud Pública. 2019;93:e201907042.
   PubMedGoogle Scholar
• GBD 2019. Tobacco collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet. 2021;397(10292):2337–2360. doi:10.1016/s0140-6736(21)01169-7.
   PubMed Web of Science ®Google Scholar
• Eurostat. Daily smokers of cigarettes by sex, age and income quintile. [accessed 2021 Dec 21]. https://ec.europa.eu/eurostat/databrowser/view/hlth_ehis_sk3i/default/table?lang=en
   Google Scholar
• Altieri A, Bosetti C, Talamini R, Gallus S, Franceschi S, Levi F, Dal Maso L, Negri E, La Vecchia C. Cessation of smoking and drinking and the risk of laryngeal cancer. Br J Cancer. 2002;87(11):1227–1229. doi:10.1038/sj.bjc.6600638.
   PubMed Web of Science ®Google Scholar
• Marron M, Boffetta P, Zhang ZF, Zaridze D, Wunsch-Filho V, Winn DM, Wei Q, Talamini R, Szeszenia-Dabrowska N, Sturgis EM, et al. Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol. 2010;39(1):182–196. doi:10.1093/ije/dyp291.
   PubMed Web of Science ®Google Scholar
• Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 2021;4(4):e214708. doi:10.1001/jamanetworkopen.2021.4708.
   PubMed Web of Science ®Google Scholar
• Menezes FDS, Fernandes GA, Antunes JLF, Villa LL, Toporcov TN. Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: a systematic review of population-based studies. Oral Oncol. 2021;115:105177. doi:10.1016/j.oraloncology.2020.105177.
   PubMed Web of Science ®Google Scholar
• Sebastião YV, Metzger GA, Chisolm DJ, Xiang H, Cooper JN. Impact of ICD-9-CM to ICD-10-CM coding transition on trauma hospitalization trends among young adults in 12 states. Inj Epidemiol. 2021;8(1):4. doi:10.1186/s40621-021-00298-x.
   PubMedGoogle Scholar
• Hamedani AG, Blank L, Thibault DP, Willis AW. Impact of ICD-9 to ICD-10 coding transition on prevalence trends in neurology. Neurol Clin Pract. 2021;11(5):e612–e9. doi:10.1212/cpj.0000000000001046.
   PubMedGoogle Scholar
• Grief SN, Patel J, Kochendorfer KM, Green LA, Lussier YA, Li J, Burton M, Boyd AD. Simulation of ICD-9 to ICD-10-CM transition for family medicine: simple or convoluted? J Am Board Fam Med. 2016;29(1):29–36. doi:10.3122/jabfm.2016.01.150146.
   PubMed Web of Science ®Google Scholar
• Marur S, D’-Souza G, Westra WH, Forastiere AA. HPV-Associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010;11(8):781–789. doi:10.1016/s1470-2045(10)70017-6.
   PubMed Web of Science ®Google Scholar
• Conway DI, Stockton DL, Warnakulasuriya KA, Ogden G, Macpherson LM. Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999) - recent trends and regional variation. Oral Oncol. 2006;42(6):586–592. doi:10.1016/j.oraloncology.2005.10.018.
   PubMed Web of Science ®Google Scholar
• Näsman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer. 2009;125(2):362–366. doi:10.1002/ijc.24339.
   PubMed Web of Science ®Google Scholar
• Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT, Witte BI, Baatenburg de Jong RJ, Meijer CJ, Snijders PJ, et al. Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer. 2013;132(7):1565–1571. doi:10.1002/ijc.27821.
   PubMed Web of Science ®Google Scholar
• Del Mistro A, Frayle H, Menegaldo A, Favaretto N, Gori S, Nicolai P, Spinato G, Romeo S, Tirelli G, da Mosto MC, et al. Age-Independent increasing prevalence of human papillomavirus-driven oropharyngeal carcinomas in North-East Italy. Sci Rep. 2020;10(1):9320. doi:10.1038/s41598-020-66323-z.
   PubMed Web of Science ®Google Scholar
• de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664–670. doi:10.1002/ijc.30716.
   PubMed Web of Science ®Google Scholar
• Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, Bosch FX, de Sanjosé S, Trottier H. HPV DNA E6/E7 mRNA, and p16ink4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319–1331. doi:10.1016/s1470-2045(14)70471-1.
   PubMed Web of Science ®Google Scholar
• Diz P, Meleti M, Diniz-Freitas M, Vescovi P, Warnakulasuriya S, Johnson NW, Kerr AR. Oral and pharyngeal cancer in Europe: Incidence, mortality and trends as presented to the Global Oral Cancer Forum. Transl Res Oral Oncol. 2017;2:2057178X17701517. doi:10.1177/2057178X17701517.
   Google Scholar
• Rodrigo JP, Heideman DA, García-Pedrero JM, Fresno MF, Brakenhoff RH, Díaz Molina JP, Snijders PJ, Hermsen MA. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009). Int J Cancer. 2014;134(2):487–492. doi:10.1002/ijc.28355.
   PubMed Web of Science ®Google Scholar
• Mena M, Frias-Gomez J, Taberna M, Quirós B, Marquez S, Clavero O, Baena A, Lloveras B, Alejo M, León X, et al. Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe. Sci Rep. 2020;10(1):13219. doi:10.1038/s41598-020-70118-7.
   PubMed Web of Science ®Google Scholar
• Zumsteg ZS, Cook-Wiens G, Yoshida E, Shiao SL, Lee NY, Mita A, Jeon C, Goodman MT, Ho AS. Incidence of oropharyngeal cancer among elderly patients in the United States. JAMA Oncol. 2016;2(12):1617–1623. doi:10.1001/jamaoncol.2016.1804.
   PubMed Web of Science ®Google Scholar
• Tota JE, Best AF, Zumsteg ZS, Gillison ML, Rosenberg PS, Chaturvedi AK. Evolution of the Oropharynx cancer epidemic in the United States: moderation of increasing incidence in younger individuals and shift in the burden to older individuals. J Clin Oncol. 2019;37(18):1538–1546. doi:10.1200/jco.19.00370.
   PubMed Web of Science ®Google Scholar
• Thompson JD, Harari PM, Hartig GK. Is HPV-associated oropharyngeal cancer becoming more common in older patients? Laryngoscope Invest Otolaryngol. 2018;3(6):446–449. doi:10.1002/lio2.181.
   PubMed Web of Science ®Google Scholar
• Rettig EM, Zaidi M, Faraji F, Eisele DW, El Asmar M, Fung N, D’-Souza G, Fakhry C. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of human papillomavirus is attenuated among older patients: analysis of the National Cancer Database. Oral Oncol. 2018;83:147–153. doi:10.1016/j.oraloncology.2018.06.013.
   PubMed Web of Science ®Google Scholar
• Cline BJ, Simpson MC, Gropler M, Bukatko AR, Adjei Boakye E, Mohammed KA, Osazuwa-Peters N. Change in age at diagnosis of oropharyngeal cancer in the United States, 1975–2016. Cancers (Basel). 2020;12(11):3191. doi:10.3390/cancers12113191.
   PubMed Web of Science ®Google Scholar
• Ragin CC, Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007;121(8):1813–1820. doi:10.1002/ijc.22851.
   PubMed Web of Science ®Google Scholar
• Gillison M. HPV vaccines and potential prevention of HPV-positive head and neck cancer. In: Group I, editor. Primary end-points for prophylactic HPV vaccine trials. Lyon, France: IARC Working Group Reports, No. 7. IARC HPV Working Group; 2014.
   Google Scholar
• Nielsen KJ, Jakobsen KK, Jensen JS, Gronhoj C, Von Buchwald C. The effect of prophylactic HPV vaccines on oral and oropharyngeal HPV infection-a systematic review. Viruses. 2021;13(7):1339. doi:10.3390/v13071339.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Fakhry C, D’-Souza G. Projected association of human papillomavirus vaccination with Oropharynx cancer incidence in the US, 2020-2045. JAMA Oncol. 2021;7(10):e212907. doi:10.1001/jamaoncol.2021.2907.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Supplement accelerated approval. [accessed 2021 Dec 22]. https://www.fda.gov/media/138949/download
   Google Scholar
• Osazuwa-Peters N, Graboyes EM, Khariwala SS. Expanding indications for the human papillomavirus vaccine: one small step for the prevention of head and neck cancer, but one giant leap remains. JAMA Otolaryngol Head Neck Surg. 2020;146(12):1099–1101. doi:10.1001/jamaoto.2020.4068.
   PubMed Web of Science ®Google Scholar
• Colzani E, Johansen K, Johnson H, Pastore Celentano L. Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma. Euro Surveill. 2021;26(50). doi:10.2807/1560-7917.es.2021.26.50.2001659.
   PubMedGoogle Scholar
• Parliament E Report on strengthening Europe in the fight against cancer – towards a comprehensive and coordinated strategy (2020/2267(INI)). [accessed 2022 April 06]. https://www.europarl.europa.eu/doceo/document/A-9-2022-0001_EN.pdf
   Google Scholar
• Alvarez Garcia FJ, Cilleruelo Ortega MJ, Alvarez Aldean J, Garces-Sanchez M, Garcia Sanchez N, Garrote Llanos E, Hernandez Merino A, Iofrio de Arce A, Montesdeoca Melian A, Navarro Gomez ML, et al. Immunisation schedule of the Pediatric Spanish Association: 2021 recommendations. An Pediatr (Engl Ed). 2021;94(1): 53 e1- e10. doi:10.1016/j.anpedi.2020.10.002.
   PubMed Web of Science ®Google Scholar
• Soler-Soneira M, Olmedo-Lucerón C, Sánchez-Cambronero Cejudo L, Cantero-Gudino E, Limia-Sánchez A. El Coste de vacunar a lo largo de toda la vida en España. Rev Esp Salud Publica. 2020 Internet;94(11):e1–12.
   Google Scholar
• Ethgen O, Cornier M, Chriv E, Baron-Papillon F. The cost of vaccination throughout life: a western European overview. Hum Vaccin Immunother. 2016;12(8):2029–2037. doi:10.1080/21645515.2016.1154649.
   PubMed Web of Science ®Google Scholar
• Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol. 2013;14(12):1165–1174. doi:10.1016/s1470-2045(13)70442-x.
   PubMed Web of Science ®Google Scholar
• Hofmarcher T, Lindgren P, Wilking N, Jonsson B. The cost of cancer in Europe 2018. Eur J Cancer. 2020;129:41–49. doi:10.1016/j.ejca.2020.01.011.
   PubMed Web of Science ®Google Scholar
• St Guily JL, Borget I, Vainchtock A, Rémy V, Takizawa C. Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database. Head Neck Oncol. 2010;2:22. doi:10.1186/1758-3284-2-22.
   PubMedGoogle Scholar
• Kim K, Amonkar MM, Högberg D, Kasteng F. Economic burden of resected squamous cell carcinoma of the head and neck in an incident cohort of patients in the UK. Head Neck Oncol. 2011;3:47. doi:10.1186/1758-3284-3-47.
   PubMedGoogle Scholar
• Polesel J, Lupato V, Collarile P, Vaccher E, Fanetti G, Giacomarra V, Palazzari E, Furlan C, Matrone F, Navarria F, et al. Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy. Med Oncol. 2019;36(4):31. doi:10.1007/s12032-019-1256-2.
   PubMed Web of Science ®Google Scholar
• Kusnoor SV, Blasingame MN, Williams AM, DesAutels SJ, Su J, Giuse NB. A narrative review of the impact of the transition to ICD-10 and ICD-10-CM/PCS. JAMIA Open. 2020;3(1):126–131. doi:10.1093/jamiaopen/ooz066.
   PubMedGoogle Scholar